Véronique Lamarque

419 total citations
7 papers, 288 citations indexed

About

Véronique Lamarque is a scholar working on Economics and Econometrics, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, Véronique Lamarque has authored 7 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Economics and Econometrics, 3 papers in Public Health, Environmental and Occupational Health and 3 papers in Immunology. Recurrent topics in Véronique Lamarque's work include Health Systems, Economic Evaluations, Quality of Life (3 papers), Prenatal Substance Exposure Effects (2 papers) and Biomedical Ethics and Regulation (2 papers). Véronique Lamarque is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (3 papers), Prenatal Substance Exposure Effects (2 papers) and Biomedical Ethics and Regulation (2 papers). Véronique Lamarque collaborates with scholars based in France, Switzerland and Canada. Véronique Lamarque's co-authors include Jean-Claude Guillaume, Louis Dubertret, C. Paul, Enno Christophers, Claire McGeown, Vincent Ho, Hervé Le Louët, C. Kreft-Jaïs, E. Autret‐Leca and A Castot and has published in prestigious journals such as Journal of Investigative Dermatology and Therapies.

In The Last Decade

Véronique Lamarque

6 papers receiving 275 citations

Peers

Véronique Lamarque

IMMUN

DERMA

PFM

RHEUM

EPIDE

Mitsuha Hayashi Japan

Mauro Bavetta Italy

Ofelia Baniandrés Spain

JC Prinz Germany

Katherine Armour Australia

Miriam Teoli Italy

Maria Laura Flori Italy

E. del Alcázar Spain

İnci Mevlitoğlu Türkiye

M. Krensel Germany

Mitsuha Hayashi Japan

Véronique Lamarque

241 ×1.3

IMMUN

112 ×0.9

DERMA

46 ×0.7

PFM

51 ×0.9

RHEUM

41 ×0.9

EPIDE

Citations per year, relative to Véronique Lamarque Véronique Lamarque (= 1×) peers Mitsuha Hayashi

Countries citing papers authored by Véronique Lamarque

Since Specialization

Citations

This map shows the geographic impact of Véronique Lamarque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Véronique Lamarque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Véronique Lamarque more than expected).

Fields of papers citing papers by Véronique Lamarque

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Véronique Lamarque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Véronique Lamarque. The network helps show where Véronique Lamarque may publish in the future.

Co-authorship network of co-authors of Véronique Lamarque

This figure shows the co-authorship network connecting the top 25 collaborators of Véronique Lamarque. A scholar is included among the top collaborators of Véronique Lamarque based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Véronique Lamarque. Véronique Lamarque is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Lemaire, François, Olivier Chassany, Laëtitia Gambotti, et al.. (2015). The European “Clinical Trial” Regulation: Relationship with the Jardé Act: a Giens Workshop. Therapies. 70(1). 29–36. 1 indexed citations

2.

Lemaire, François, Olivier Chassany, Philippe Barthélémy, et al.. (2015). Le règlement européen « essais cliniques » : articulation avec la loi Jardé : un atelier de Giens. Therapies. 70(1). 21–28.

3.

Lamarque, Véronique, Louis Merle, Haleh Bagheri, et al.. (2008). Génériques et modalités de substituabilité : propositions de méthodes pour évaluer l’équivalence, la traçabilité et le relevé de Pharmacovigilance. Therapies. 63(4). 301–309. 3 indexed citations

4.

Lamarque, Véronique, Louis Merle, Haleh Bagheri, et al.. (2008). Generics and Substitution Modalities: Proposed Methods for the Evaluation of Equivalence, Traceability and Pharmacovigilance Reporting. Therapies. 63(4). 311–319. 4 indexed citations

5.

Jacqz-Aigrain, Évelyne, Véronique Lamarque, E. Autret‐Leca, et al.. (2006). Méthodes de surveillance et de gestion des risques des médicaments pour la future mère, l’embryon, le fœtus et le nouveau-né. Therapies. 61(4). 287–295. 2 indexed citations

6.

Jacqz-Aigrain, Évelyne, Véronique Lamarque, E. Autret‐Leca, et al.. (2006). Risk Management and Monitoring Methods for the Future Mother, Embryo, Fetus, and post-natal Consequences. Therapies. 61(4). 297–304. 2 indexed citations

7.

Paul, C., Vincent Ho, Claire McGeown, et al.. (2003). Risk of Malignancies in Psoriasis Patients Treated with Cyclosporine: a 5 y Cohort Study. Journal of Investigative Dermatology. 120(2). 211–216. 276 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact